§ PP-021IGF analogue

IGF-1 LR3

Long-Arg3 IGF-1

Long Arg3 insulin-like growth factor 1 analogue. Isolated for its structural simplicity and synthetic accessibility, IGF-1 LR3 is produced as a lyophilised solid and sealed under inert atmosphere.

Every batch moves through the full Six-Step protocol — solid-phase Fmoc synthesis, TFA cleavage, reverse-phase HPLC purification, and ESI-TOF mass-spec confirmation. The lot shipped carries ≥ 99% HPLC-MS purity with residual solvent and endotoxin assays signed by an independent laboratory.

Lyophilised vials are stable at −20 °C in their sealed amber container. In reconstitution solution, HPLC-verified purity holds for approximately four weeks under refrigeration; single-thaw only.

Sequence: TBD
Molecular weight: 0 g/mol
Purity (HPLC-MS): 99%
Dose · fill: 1 mg
Lot number: TBD
CoA date: TBD
Storage: −20 °C · thaw once
Shipping: Cold-chain, 1-day overnight

View Certificate of Analysis Synthesis protocol→

REC · 00:00:08

Spec. PP-021

Lot TBD

Subject

IGF-1 LR3 · 1 mg · lyophilised

0 g/mol

Fig. — Amber borosilicate vial, argon-flushed, 1 mg fill.

Specifications

Lot: TBD
Dose: 1 mg
In stock: 80 vials
Dispatch: Within 24h
Storage: −20 °C · thaw once

Price

USD$49.99

Ships in 1–2 business days

Certificate of analysis

The certificate for lot — (1 mg) is with the laboratory. It is published here as soon as it is issued — or email support@thepurepep.com and we will send it when it lands.

§ 03Related monographs